Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid

BioTechGrid

  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
Posted inBiotechnology

Lightweight AI Reads Brain Tumor Scans and Knows When It Is Unsure

October 14, 2026
Continue Reading
lightweight-ai-reads-brain-tumor-scans-and-knows-when-it-is-unsure
Posted inBiotechnology

Blood Type Offers No Shield Against Common Skin Warts, Study Finds

October 14, 2026
Continue Reading
blood-type-offers-no-shield-against-common-skin-warts,-study-finds
Posted inBiotechnology

New AI Framework Blends Infrared and Visible Images by Seeing Others and Focusing Itself

October 14, 2026
Continue Reading
new-ai-framework-blends-infrared-and-visible-images-by-seeing-others-and-focusing-itself
Posted inBiotechnology

Sick Leeches Keep Their Microbial Diversity but Lose Their Microbial Stability

October 14, 2026
Continue Reading
sick-leeches-keep-their-microbial-diversity-but-lose-their-microbial-stability
Posted inBiotechnology

Brain Tumor Biomarker Survives Tough Test: MGMT Signal Holds After Batch Effect Scrutiny

October 14, 2026
Continue Reading
brain-tumor-biomarker-survives-tough-test:-mgmt-signal-holds-after-batch-effect-scrutiny
Posted inBiotechnology

UTHealth Houston Scientist Wins $12 Million to Probe Brain Energy and Aging

October 14, 2026
Continue Reading
uthealth-houston-scientist-wins-$12-million-to-probe-brain-energy-and-aging
Most Popular Post
exploring-the-future-of-healthcare with-panos-karelis
Posted inArtificial intelligence

Exploring the Future of Healthcare with Panos Karelis

exploring-the-future-of-healthcare with-gordon-wishart,-check4cancer
Posted inArtificial intelligence

Exploring the Future of Healthcare with Gordon Wishart, Check4Cancer

exploring-the-future-of-healthcare with-noam-shomron,-tel-aviv-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Noam Shomron, Tel Aviv University

exploring-the-future-of-healthcare with-raul-villamarin-rodriguez,-woxsen-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Raul Villamarin Rodriguez, Woxsen University

creating-true-and-false-memories-from-forgotten-information-in-drosophila
Posted inBiotechnology

Creating true and false memories from forgotten information in Drosophila

July 30, 2026
Yang, W., Zattera, B., Pavão-Delgado, M. et al. Creating true and false memories from forgotten information in Drosophila. Nat Neurosci…
Read More
complement-deficiency-and-neonatal-immunity:-a-serum-limited,-context-dependent-framework
Posted inBiotechnology

Complement deficiency and neonatal immunity: a serum-limited, context-dependent framework

July 30, 2026
Carmi, D., Gabbay, U. Complement deficiency and neonatal immunity: a serum-limited, context-dependent framework. Pediatr Res (2026). https://doi.org/10.1038/s41390-026-05320-w 30 July 2026
Read More
senotypes-define-the-diverse-landscape-of-senescent-cells
Posted inBiotechnology

Senotypes define the diverse landscape of senescent cells

July 30, 2026
Cellular senescence was initially defined in vitro as a stable cell-cycle arrest that occurs after repeated replication, but it is…
Read More
latigo-reports-positive-phase-iib-data-for-non-opioid-acute-pain-candidate
Posted inGenetics

Latigo Reports Positive Phase IIb Data for Non-Opioid Acute Pain Candidate

July 30, 2026
Latigo Biotherapeutics’ cold pressor test (CPT), the methodology of which the company says it has identified and refined as a…
Read More
Posted inBiotechnology

BMS CEO Boerner doesn’t ‘feel any compulsion to chase deals’ despite lack of M&A this year

July 30, 2026
BMS may have been absent from the dealmaking spree of some of its Big Pharma peers this year, but that…
Read More
non-invasive-biomarkers-for-early-oral-cancer-detection-through-multiomics-approach
Posted inBiotechnology

Non-invasive biomarkers for early oral cancer detection through multiomics approach

July 30, 2026
Non-invasive biomarker-based approaches are urgently needed to support early identification and monitoring of Oral squamous cell carcinoma (OSCC) and its…
Read More
cuau-alloy-electrocatalyst-enables-biomass-upgrading-and-bipolar-hydrogen-production-at-ultralow-voltage
Posted inBiotechnology

CuAu alloy electrocatalyst enables biomass upgrading and bipolar hydrogen production at ultralow voltage

July 30, 2026
image: CuAu alloys with tailored compositions were integrated onto copper foam by a simple one-step electrodeposition method. The optimized Cu0.25Au0.75 catalyst…
Read More
wistar-scientists-identify-fructose-as-a-surprise-driver-of-cancer-spread
Posted inBiotechnology

Wistar scientists identify fructose as a surprise driver of cancer spread

July 30, 2026
image: (On Right) Dr. Katherine Aird with members of her lab view more  Credit: The Wistar Institute A new study from…
Read More
neonatal-transport-for-convalescing-infants:-occurrence-and-barriers-reported-by-providers
Posted inBiotechnology

Neonatal transport for convalescing infants: occurrence and barriers reported by providers

July 30, 2026
Womack-Martenson, L.S., Manning, S.E., Rohan, A. et al. Neonatal transport for convalescing infants: occurrence and barriers reported by providers. J…
Read More
Posted inBiotechnology

Attovia, Braveheart and Vogenx seek more than $500M across trio of IPOs

July 30, 2026
Attovia Therapeutics, Braveheart Bio and Vogenx have set target ranges for their IPOs, positioning the trio to collectively net more…
Read More

Posts pagination

Previous page 1 … 328 329 330 331 332 … 383 Next page
You May Have Missed
Posted inMedical Technology

VertigoDx on firm ground with FDA greenlight for vertigo diagnostic system

Posted inMedical Technology

Precision Neuroscience taps $250M in Series D funding for brain-computer interface

Posted inMedical Technology

VC Sofinnova reels in €82M to target medtechs in the next 5 years

Posted inMedical Technology

Adagio Medical kicks off strategic review, trims more than half its staff

Privacy Policy    Terms

Scroll to Top